These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 22470120)
21. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Via LE; Lin PL; Ray SM; Carrillo J; Allen SS; Eum SY; Taylor K; Klein E; Manjunatha U; Gonzales J; Lee EG; Park SK; Raleigh JA; Cho SN; McMurray DN; Flynn JL; Barry CE Infect Immun; 2008 Jun; 76(6):2333-40. PubMed ID: 18347040 [TBL] [Abstract][Full Text] [Related]
22. Metronidazole lacks activity against Mycobacterium tuberculosis in an in vivo hypoxic granuloma model of latency. Klinkenberg LG; Sutherland LA; Bishai WR; Karakousis PC J Infect Dis; 2008 Jul; 198(2):275-83. PubMed ID: 18491971 [TBL] [Abstract][Full Text] [Related]
23. Comparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis. De Groote MA; Gilliland JC; Wells CL; Brooks EJ; Woolhiser LK; Gruppo V; Peloquin CA; Orme IM; Lenaerts AJ Antimicrob Agents Chemother; 2011 Mar; 55(3):1237-47. PubMed ID: 21135176 [TBL] [Abstract][Full Text] [Related]
25. In-Vivo Gene Signatures of Mycobacterium tuberculosis in C3HeB/FeJ Mice. Gautam US; Mehra S; Kaushal D PLoS One; 2015; 10(8):e0135208. PubMed ID: 26270051 [TBL] [Abstract][Full Text] [Related]
26. Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models. Ahmad Z; Fraig MM; Pinn ML; Tyagi S; Nuermberger EL; Grosset JH; Karakousis PC J Antimicrob Chemother; 2011 Jul; 66(7):1560-6. PubMed ID: 21602551 [TBL] [Abstract][Full Text] [Related]
27. Importance of confirming data on the in vivo efficacy of novel antibacterial drug regimens against various strains of Mycobacterium tuberculosis. De Groote MA; Gruppo V; Woolhiser LK; Orme IM; Gilliland JC; Lenaerts AJ Antimicrob Agents Chemother; 2012 Feb; 56(2):731-8. PubMed ID: 22143517 [TBL] [Abstract][Full Text] [Related]
29. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis. Byrne ST; Denkin SM; Zhang Y J Antimicrob Chemother; 2007 Feb; 59(2):313-6. PubMed ID: 17185297 [TBL] [Abstract][Full Text] [Related]
30. Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis. Ahmad Z; Tyagi S; Minkowsk A; Almeida D; Nuermberger EL; Peck KM; Welch JT; Baughn AS; Jacobs WR; Grosset JH Indian J Med Res; 2012 Nov; 136(5):808-14. PubMed ID: 23287128 [TBL] [Abstract][Full Text] [Related]
31. Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis. Henao-Tamayo M; Obregón-Henao A; Creissen E; Shanley C; Orme I; Ordway DJ Clin Vaccine Immunol; 2015 Jan; 22(1):91-8. PubMed ID: 25392011 [TBL] [Abstract][Full Text] [Related]
32. The search for new sterilizing anti-tuberculosis drugs. Mitchison DA Front Biosci; 2004 May; 9():1059-72. PubMed ID: 14977529 [TBL] [Abstract][Full Text] [Related]
33. Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice. Dutta NK; Illei PB; Jain SK; Karakousis PC Am J Pathol; 2014 Jul; 184(7):2045-55. PubMed ID: 24815353 [TBL] [Abstract][Full Text] [Related]
34. Clofazimine protects against Mycobacterium tuberculosis dissemination in the central nervous system following aerosol challenge in a murine model. Baijnath S; Moodley C; Ngcobo B; Singh SD; Kruger HG; Arvidsson PI; Naicker T; Pym A; Govender T Int J Antimicrob Agents; 2018 Jan; 51(1):77-81. PubMed ID: 28843822 [TBL] [Abstract][Full Text] [Related]
35. Activity of ketoconazole against Mycobacterium tuberculosis in vitro and in the mouse model. Byrne ST; Denkin SM; Gu P; Nuermberger E; Zhang Y J Med Microbiol; 2007 Aug; 56(Pt 8):1047-1051. PubMed ID: 17644711 [TBL] [Abstract][Full Text] [Related]
36. Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas. Skerry C; Harper J; Klunk M; Bishai WR; Jain SK PLoS One; 2012; 7(6):e39680. PubMed ID: 22761866 [TBL] [Abstract][Full Text] [Related]
37. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)]. Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898 [TBL] [Abstract][Full Text] [Related]
38. Ultra-rapid near universal TB drug regimen identified via parabolic response surface platform cures mice of both conventional and high susceptibility. Lee BY; Clemens DL; Silva A; Dillon BJ; Masleša-Galić S; Nava S; Ho CM; Horwitz MA PLoS One; 2018; 13(11):e0207469. PubMed ID: 30427938 [TBL] [Abstract][Full Text] [Related]
39. Preclinical Evaluation of Inhalational Spectinamide-1599 Therapy against Tuberculosis. Gonzalez-Juarrero M; Lukka PB; Wagh S; Walz A; Arab J; Pearce C; Ali Z; Ryman JT; Parmar K; Temrikar Z; Munoz-Gutierrez J; Robertson GT; Liu J; Lenaerts AJ; Daley C; Lee RE; Braunstein M; Hickey AJ; Meibohm B ACS Infect Dis; 2021 Oct; 7(10):2850-2863. PubMed ID: 34546724 [TBL] [Abstract][Full Text] [Related]